Peptris Technologies Pvt. Ltd
June 22, 2026
Theater 4
Type: Company Presentation
Focus Area:
Orphan and Rare Disease
Peptris is an AI powered preclinical drug discovery company with focus on rare diseases, inflammation, oncology, and Women's Health. Peptris has created AI models to generate novel molecules and predict varied parameters that are critical for drug development. The approach has led to discovery of Novel Chemical Entities (NCE) and drug repurpose and rescue opportunities. The platform has been used to discover NCEs, to repurpose or reposition approved drugs, and rescue molecules that have been proven safe in the clinic. The proprietary AI process and 4 assets that have been validated in preclinical in vivo models have been patented.
Company HQ City:
Bangalore
Company HQ State:
Karnataka
Company HQ Country:
India
Year Founded:
2019
Lead Product in Development:
PEPR124
CEO
Narayanan Venkatasubramanian
Development Phase of Lead Product
Phase II
Number of Unlicensed Products Looking for Licensing
4
When you expect your next catalyst update?
Dec 2027
What is your next catalyst (value inflection) update?
Clinical Trial start for our NCE program
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}